Formulary guidance and transparency from P&T to point of care

Trends That Matter for Multiple Sclerosis

Posted by Matt Breese on Dec 7, 2017

Find me on:


In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is multiple sclerosis treatments. 

According to our recent payer coverage analysis for multiple sclerosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

Here are some recent trends:

  • Long-Term Care Utilization: Recent data from Specialty Pharmacy Times shows that the past year was the first in which neurologists led the way in scripts by LTC facility patients. While we see this trend in this segment specifically, this may signal a shift in prescribing across other channels in coming years.
  • Pricier Treatments Bring More Pressures: Treatments in the highly managed disease area of MS are often lumped in with other “expensive drugs”. Prescribers in this space are challenged by both complex patient treatment plans as well as drug coverage and access decisions.

To learn more about this topic, download MMIT's Reality Check by clicking on the button below: 

View Reality Check 

Topics: Specialty, Industry Trends